Monthly Archives: January 2012

TOPAMAX, Already in Hot Water over Off-Label Promotion, Now Linked to Birth Defects

By John Saponaro – Off-label promotion has become an ongoing issue over the past several years as pharmaceutical companies continue to violate government policies by advertising drugs for [..]

Study Says, Nursing Home Residents Are Being Prescribed Antipsychotic Drugs Regardless of Potentially Hazardous Side Effects

By Devon Reiff – According to a recent report by The Department of Health and Human Services (HHS) Office of the Inspector General (OIG), many nursing home residents [..]

Is Abilify Worth The Risk?

The pros and cons of aripiprazole By Arnold Di Joseph – The popular prescription antipsychotic drug aripiprazole, commonly known as Abilify, is an “atypical antipsychotic” that can lead [..]

Is the Taser Really a “Non-Lethal” Weapon?

Numerous deaths associated with the device raise questions about its safety By Stef Morisi – In recent years, law enforcement agencies nationwide have sought to integrate a number [..]

Studies Show that there is Good Reason to be concerned About the Widespread Use of Phthalates

By Robert A. Cardali – There is currently a growing debate regarding the safety of a group of chemicals used in many personal care products and other consumer [..]

When Incorrect Doses Of Over-The-Counter Cold Remedies Are Given, Infants Die

Other common drug-related errors also expose infants to potentially deadly results By Arnold DiJoseph – In the past several years, there has been an ever-increasing awareness of the [..]

Studies Show Serious Risks Still Exist When Treating Children and Adolescents for Psychiatric Problems with Multiple Medications

By Robert A. Cardali – In medical terms, it’s called “polypharmacy” or “concomitant psychotropic medication.” Laymen know it as multiple-medication. When it comes to what is being done [..]